Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Burden of thyroid cancer in North Africa and Middle East 1990-2019.
Nejadghaderi SA, Moghaddam SS, Azadnajafabad S, Rezaei N, Rezaei N, Tavangar SM, Jamshidi H, Mokdad AH, Naghavi M, Farzadfar F, Larijani B; GBD 2019 NAME Thyroid Cancer Collaborators. Nejadghaderi SA, et al. Among authors: rezaei n. Front Oncol. 2022 Sep 23;12:955358. doi: 10.3389/fonc.2022.955358. eCollection 2022. Front Oncol. 2022. PMID: 36212501 Free PMC article.
Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis.
Rezaei N, Asadi-Lari M, Sheidaei A, Khademi S, Gohari K, Delavari F, Delavari A, Abdolhamidi E, Chegini M, Rezaei N, Jamshidi H, Bahrami Taghanaki P, Hasan M, Yoosefi M, FarzadFar F. Rezaei N, et al. PLoS One. 2019 Jan 15;14(1):e0198449. doi: 10.1371/journal.pone.0198449. eCollection 2019. PLoS One. 2019. PMID: 30645598 Free PMC article.
Points to Consider Regarding Tobacco Hindrance.
Rezaei N, Farzadfar F. Rezaei N, et al. Arch Iran Med. 2020 May 1;23(5):353-355. doi: 10.34172/aim.2020.25. Arch Iran Med. 2020. PMID: 32383620 Free article. No abstract available.
Non-communicable diseases' risk factors in Iran; a review of the present status and action plans.
Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, Rezaei N, Naderimagham S, Larijani B, Farzadfar F. Azadnajafabad S, et al. Among authors: rezaei s, rezaei n. J Diabetes Metab Disord. 2021 Jan 22;23(2):1-9. doi: 10.1007/s40200-020-00709-8. Online ahead of print. J Diabetes Metab Disord. 2021. PMID: 33500879 Free PMC article. Review.
Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction; questioning the current diagnostic criteria.
Mohammadi E, Morasa FS, Roshani S, Rezaei N, Azadnajafabad S, Moghaddam SS, Azmin M, Karimian M, Fattahi N, Jamshidi K, Ebrahimi N, Khalilabad MR, Naderimagham S, Larijani B, Farzadfar F. Mohammadi E, et al. Among authors: rezaei n. J Diabetes Metab Disord. 2020 Nov 16;19(2):1423-1430. doi: 10.1007/s40200-020-00663-5. eCollection 2020 Dec. J Diabetes Metab Disord. 2020. PMID: 33520844 Free PMC article.
1,662 results